PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MNHYX vs. SWAV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between MNHYX and SWAV is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

MNHYX vs. SWAV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Manning & Napier High Yield Bond Series (MNHYX) and ShockWave Medical, Inc. (SWAV). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%1,000.00%JulyAugustSeptemberOctoberNovemberDecember
37.15%
997.54%
MNHYX
SWAV

Key characteristics

Returns By Period


MNHYX

YTD

7.58%

1M

-1.01%

6M

3.18%

1Y

8.15%

5Y*

4.95%

10Y*

5.48%

SWAV

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MNHYX vs. SWAV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Manning & Napier High Yield Bond Series (MNHYX) and ShockWave Medical, Inc. (SWAV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MNHYX, currently valued at 2.92, compared to the broader market-1.000.001.002.003.004.002.923.63
The chart of Sortino ratio for MNHYX, currently valued at 3.97, compared to the broader market-2.000.002.004.006.008.0010.003.977.97
The chart of Omega ratio for MNHYX, currently valued at 1.66, compared to the broader market0.501.001.502.002.503.003.501.662.82
The chart of Calmar ratio for MNHYX, currently valued at 3.60, compared to the broader market0.002.004.006.008.0010.0012.0014.003.602.02
The chart of Martin ratio for MNHYX, currently valued at 18.65, compared to the broader market0.0020.0040.0060.0018.6569.01
MNHYX
SWAV


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00JulyAugustSeptemberOctoberNovemberDecember
2.92
3.63
MNHYX
SWAV

Dividends

MNHYX vs. SWAV - Dividend Comparison

MNHYX's dividend yield for the trailing twelve months is around 4.80%, while SWAV has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
MNHYX
Manning & Napier High Yield Bond Series
4.80%6.67%5.67%4.57%5.00%6.64%5.26%5.17%6.50%5.61%4.97%5.00%
SWAV
ShockWave Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

MNHYX vs. SWAV - Drawdown Comparison


-2.00%-1.50%-1.00%-0.50%0.00%JulyAugustSeptemberOctoberNovemberDecember
-2.20%
-0.02%
MNHYX
SWAV

Volatility

MNHYX vs. SWAV - Volatility Comparison

Manning & Napier High Yield Bond Series (MNHYX) has a higher volatility of 1.41% compared to ShockWave Medical, Inc. (SWAV) at 0.00%. This indicates that MNHYX's price experiences larger fluctuations and is considered to be riskier than SWAV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%0.50%1.00%1.50%JulyAugustSeptemberOctoberNovemberDecember
1.41%
0
MNHYX
SWAV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab